Clinical trial design in neonatal pharmacology: effect of center differences, with lessons from the Pediatric Oncology Cooperative Research experience.
Journal Article (Journal Article)
Survival for premature neonates has improved dramatically over the past 20 years; however, there has been minimal improvement in prematurity-associated morbidities. Morbidity rates and assessment of outcomes vary across neonatology intensive care units (NICUs). Here, we address the reasons underlying these differences, note the impact that this center variation has on trial design and interpretation, and highlight the success of the efforts in pediatric oncology to develop standards of care through the conduct of multicenter clinical trials.
Full Text
Duke Authors
Cited Authors
- Moran, C; Smith, PB; Cohen-Wolkowiez, M; Benjamin, DK
Published Date
- December 2009
Published In
Volume / Issue
- 86 / 6
Start / End Page
- 589 - 591
PubMed ID
- 19915602
Pubmed Central ID
- PMC2782890
Electronic International Standard Serial Number (EISSN)
- 1532-6535
Digital Object Identifier (DOI)
- 10.1038/clpt.2009.175
Language
- eng
Conference Location
- United States